The need for precision management in glaucoma moves field forward
August 8th 2022Genotyping and artificial intelligence are together starting to predict the progression of glaucoma in individual patients, sparing them from suboptimal treatments and side effects. Recent research efforts are exploring modifiable risk factors such as caffeine consumption.
First-ever retinal gene therapy: Does real-world experience back its use?
Recent reports of retinal atrophy have raised concerns on potential long-term safety.